Safety and efficacy of CHOP for treatment of diffuse large B-cell lymphoma with different cART regimens: SCULPT study

Antiviral Therapy ◽

10.3851/imp2572 ◽

2013 ◽

Vol 18 (5) ◽

pp. 699-707 ◽

Author(s):

Alison YJ Wong ◽

Suzanne Marcotte ◽

Mathieu Laroche ◽

Nancy L Sheehan ◽

Vishal Kukreti ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Download Full-text

A Study to Evaluate the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab, Gemcitabine and Oxaliplatin Compared to Rituximab, Gemcitabine and Oxaliplatin Alone in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04182204 ◽

2019 ◽

Author(s):

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Download Full-text

Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma

Case Medical Research ◽

10.31525/ct1-nct04250324 ◽

2020 ◽

Author(s):

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Download Full-text

Safety and efficacy of GVD and anti-PD-1 (SHR-1210) regimen with or without low-dose decitabine priming for refractory bulky and aggressive primary mediastinal large B-cell lymphoma.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.7556 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 7556-7556 ◽

Author(s):

Wenying Zhang ◽

Yang Liu ◽

Qian Mei ◽

Lianjun Shen ◽

Qingming Yang ◽

...

Keyword(s):

B Cell ◽

Low Dose ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Download Full-text

Abstract CT162: The phase 1b PORTIA study: Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL)

10.1158/1538-7445.am2020-ct162 ◽

2020 ◽

Author(s):

Ulrich Jaeger ◽

Nina Worel ◽

Joseph P. McGuirk ◽

Peter A. Riedell ◽

Isabelle Fleury ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Download Full-text

Poster: ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01501-9 ◽

2021 ◽

Vol 21 ◽

pp. S239

Author(s):

Adam Olszewski ◽

Abraham Avigdor ◽

Sunil Babu ◽

Itai Levi ◽

Herbert Eradat ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Unfit Patients ◽

Download Full-text

ABCL-366: Mosunetuzumab (Mosun) Monotherapy for Elderly/Unfit Patients with First-Line Diffuse Large B-Cell Lymphoma (DLBCL) Continues to Show Promising Safety and Efficacy with Durable Complete Responses

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01896-6 ◽

2021 ◽

Vol 21 ◽

pp. S395-S396

Author(s):

Adam Olszewski ◽

Abraham Avigdor ◽

Sunil Babu ◽

Itai Levi ◽

Herbert Eradat ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Unfit Patients ◽

Download Full-text

SAFETY AND EFFICACY OF CD37‐TARGETING NARATUXIMAB EMTANSINE PLUS RITUXIMAB IN DIFFUSE LARGE B‐CELL LYMPHOMA AND OTHER NON‐HODGKIN’S B‐CELL LYMPHOMAS – A PHASE 2 STUDY

Hematological Oncology ◽

10.1002/hon.156_2880 ◽

2021 ◽

Vol 39 (S2) ◽

Author(s):

M. Y. Levy ◽

Z. Grudeva‐Popova ◽

M. Trneny ◽

W. Jurczak ◽

H. Pylypenko ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Phase 2 ◽

B Cell Lymphomas ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Phase 2 Study ◽

Download Full-text

Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial

The Lancet Haematology ◽

10.1016/s2352-3026(16)30040-0 ◽

2016 ◽

Vol 3 (7) ◽

pp. e309-e316 ◽

Author(s):

Patrick B Johnston ◽

Betsy LaPlant ◽

Ellen McPhail ◽

Thomas M Habermann ◽

David J Inwards ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

Phase 1 ◽

B Cell Lymphoma ◽

Feasibility Trial ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Download Full-text

Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Either Rituximab or Lenalidomide in Participants With Refractory Large B-Cell Lymphoma (ZUMA-14)

Case Medical Research ◽

10.31525/ct1-nct04002401 ◽

2019 ◽

Author(s):

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Download Full-text

A Phase 1b Study to Evaluate the Safety and Efficacy of Durvalumab in Combination with Tremelimumab or Danvatirsen in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2020.12.012 ◽

2020 ◽

Author(s):

Vincent Ribrag ◽

Seung Tae Lee ◽

David Rizzieri ◽

Martin JS. Dyer ◽

Luis Fayad ◽

...

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

Safety And Efficacy ◽

Large B Cell Lymphoma ◽

Phase 1B ◽

Download Full-text